happy news | dishuo becken was recognized as “pudong new area enterprise research and development organization in 2018”-九游会ag

recently, the pudong new area science and economic commission, in accordance with the provisions and requirements of “measures for the recognition and management of enterprise r&d institutions in pudong new area” (no. 46 of hupuke [2016]), approved 85 r&d institutions as r&d institutions of enterprises in pudong new area in 2018, and shanghai dishuo becken medical inspection co., ltd. (hereinafter referred to as “short for short”). “dishuo becken” ranked on the list and was recognized as “pudong new area enterprise research and development agency in 2018”.

tissue bank has been developing a series of original biotechnologies around the human tissue compatibility system since its inception to solve the need for clinical diagnosis. the company focuses on a series of important subjects of host reaction between human tissues and tissues, between tissues and foreign antigen factors. it solves a series of clinical problems such as tissue recognition, tissue rejection, and host response. it solves clinical immunity from three levels: genetic immunity, humoral immunity, immunity and other factors. diagnosis is an important subject. the company starts with transplantation immunity, extends to nerve immunity and tumor immunity, and finally completes the construction of big data of immune metabolism and immune fingerprint, and establishes the industrialization road of precise medical treatment. the company is committed to the “national layout of special immune clinical diagnosis platform”, “transplantation immunity to neuroimmunity leap” and “technology development to source innovation leap” three construction, to achieve the overall layout of special immune system clinical testing platform.